We use cookies and similar tools to give you the best website experience. By using our site, you accept our Websites Privacy Policy.
Patient Care, In the Media, Translational Medicine
Dr. Maya Dimitrova says tumor-infiltrating lymphocyte therapy could expand available melanoma treatments.
September 10, 2022
The combination of olaparib and bevacizumab represents a new standard of care, Dr. Eva Chalas says.
September 9, 2022
Patient Care, Translational Medicine, Press Releases
Dr. Oren Cahlon has been appointed senior vice president and deputy chief clinical officer.
September 7, 2022
Research, Translational Medicine, Press Releases
Dr. Elisabeth J. Cohen is enhancing the department’s longstanding commitment to research.
Together, psilocybin and psychotherapy reduced alcohol consumption by 83 percent among heavy drinkers.
August 24, 2022
Research, Patient Care, Translational Medicine
Dr. Elaine Shum is leading this trial, which aims to fill an unmet need for targeted therapies.
July 27, 2022
Patient Care, Translational Medicine
Joining the Experimental Therapeutics Clinical Trials Network advances cancer clinical trial capabilities.
July 21, 2022
Research, Translational Medicine
Adjuvant immunotherapy could help people avoid treatment for metastatic melanoma.
July 20, 2022
Dr. Catherine S. Diefenbach serves as the principal investigator for numerous lymphoma clinical trials.
Research, In the Media, Translational Medicine
Dr. Jeffrey Weber says a person’s microbiome may impact the effectiveness of checkpoint inhibitor therapy.
July 8, 2022
We can help you find a doctor. Call 646-929-7800 or browse our specialists.